$86.1 Million is the total value of Amia Capital LLP's 35 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 13.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GRFS | Sell | GRIFOLS S Asp adr rep b nvt | $22,477,000 | -21.9% | 1,295,478 | -17.9% | 26.12% | +10.5% |
| LSXMK | Sell | LIBERTY MEDIA CORP DEL | $12,166,000 | -37.1% | 367,779 | -34.5% | 14.14% | -11.1% |
| LSXMA | Sell | LIBERTY MEDIA CORP DEL | $11,738,000 | -37.8% | 353,877 | -35.3% | 13.64% | -12.0% |
| VALE | Buy | VALE S Asponsored ads | $9,522,000 | +163.8% | 900,000 | +157.1% | 11.06% | +273.0% |
| PBR | Buy | PETROLEO BRASILEIRO SA PETROsponsored adr | $9,256,000 | +6.6% | 1,300,000 | +23.8% | 10.76% | +50.7% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $2,019,000 | -24.2% | 42,552 | -5.9% | 2.35% | +7.1% |
| BBL | Sell | BHP GROUP PLCsponsored adr | $1,704,000 | -90.3% | 39,933 | -90.7% | 1.98% | -86.3% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $1,533,000 | -31.3% | 15,939 | -12.9% | 1.78% | -2.9% |
| INCY | Sell | INCYTE CORP | $1,430,000 | -30.5% | 15,939 | -19.5% | 1.66% | -1.7% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $1,368,000 | -35.9% | 5,026 | -31.6% | 1.59% | -9.4% |
| ARGX | Sell | ARGENX SEsponsored adr | $1,333,000 | +11.4% | 5,077 | -4.5% | 1.55% | +57.4% |
| MRNA | Sell | MODERNA INC | $1,246,000 | -12.0% | 17,607 | -20.1% | 1.45% | +24.4% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $1,010,000 | -27.5% | 6,937 | -26.2% | 1.17% | +2.5% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $953,000 | -22.6% | 36,279 | -21.0% | 1.11% | +9.4% |
| MYOK | Sell | MYOKARDIA INC | $878,000 | +27.8% | 6,437 | -9.5% | 1.02% | +80.5% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $808,000 | -3.3% | 7,061 | -5.2% | 0.94% | +36.7% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $761,000 | -35.6% | 21,740 | -1.6% | 0.88% | -9.0% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $761,000 | -29.1% | 20,464 | -2.1% | 0.88% | +0.2% |
| MGNX | Sell | MACROGENICS INC | $608,000 | -14.2% | 24,131 | -5.0% | 0.71% | +21.1% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $512,000 | -22.1% | 19,972 | -22.0% | 0.60% | +10.2% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $467,000 | +56.2% | 7,644 | +6.2% | 0.54% | +120.7% |
| RDUS | Buy | RADIUS HEALTH INC | $440,000 | -16.2% | 38,841 | +0.8% | 0.51% | +18.6% |
| FATE | Buy | FATE THERAPEUTICS INC | $408,000 | +73.6% | 10,209 | +49.3% | 0.47% | +145.6% |
| EXEL | Sell | EXELIXIS INC | $378,000 | 0.0% | 15,479 | -2.9% | 0.44% | +41.2% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $366,000 | +21.6% | 4,374 | +6.6% | 0.42% | +72.1% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $353,000 | -36.7% | 25,111 | -7.2% | 0.41% | -10.7% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $262,000 | -3.0% | 14,821 | +0.1% | 0.30% | +36.9% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $237,000 | -30.5% | 14,301 | -2.9% | 0.28% | -1.8% |
| BDTX | Buy | BLACK DIAMOND THERAPEUTICS I | $229,000 | +11.2% | 7,589 | +55.3% | 0.27% | +57.4% |
| MTEM | New | MOLECULAR TEMPLATES INC | $205,000 | – | 18,808 | +100.0% | 0.24% | – |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $199,000 | +2.6% | 21,018 | -2.9% | 0.23% | +45.3% |
| VYGR | Sell | VOYAGER THERAPEUTICS INC | $156,000 | -17.9% | 14,632 | -2.9% | 0.18% | +16.0% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $121,000 | -14.2% | 14,211 | +5.2% | 0.14% | +21.6% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $112,000 | +64.7% | 23,154 | +76.6% | 0.13% | +132.1% |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $44,000 | -25.4% | 15,408 | -4.1% | 0.05% | +6.2% |
| AKCA | Exit | AKCEA THERAPEUTICS INC | $0 | – | -13,761 | -100.0% | -0.16% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -6,974 | -100.0% | -0.19% | – |
| QQQ | Exit | INVESCO QQQ TRcall | $0 | – | -46,800 | -100.0% | -0.38% | – |
| IBB | Exit | ISHARES TRnasdaq biotech | $0 | – | -5,015 | -100.0% | -0.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PETROLEO BRASILEIRO SA PETRO | 13 | Q4 2022 | 25.8% |
| LIBERTY MEDIA CORP DELAWARE | 9 | Q4 2021 | 21.7% |
| LIBERTY MEDIA CORP DELAWARE | 9 | Q4 2021 | 21.6% |
| GRIFOLS S A | 7 | Q2 2021 | 32.3% |
| BHP GROUP PLC | 7 | Q4 2021 | 14.5% |
| VALE S A | 6 | Q4 2021 | 11.1% |
| ISHARES TR | 5 | Q1 2022 | 8.6% |
| UBS GROUP AG REG | 5 | Q2 2023 | 2.3% |
| MODERNA INC | 5 | Q3 2021 | 1.4% |
| ISHARES TR | 4 | Q3 2023 | 79.7% |
View Amia Capital LLP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-16 |
View Amia Capital LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.